.svg?iar=0&rev=04f97e5917f74dd7ba31609dd2679b85&hash=B48BFC8A4E413DB0B57E3C88497F951F){kind=logo}
/hfh-logo-main--white.svg?iar=0&rev=576e614e7a874290969b550a5935b275&hash=06AF579720DC0ECD15AAE5D6729FB49C){kind=logo}
Section Menu
Research in Urology
AUI VUI Presentations
-
AUA VUI 2023 Presentations
Presentor
Presentation
Matt Davis 23-1415 Frequentist and Bayesian Analysis of Potential Adverse Events of the COVID-19 Immunization Matt Davis 23-6375 Industry Payments to Urologists Since the Sunshine Act Matt Davis 23-6404 Industry Payments to Urologists Since the COVID-19 Pandemic Matt Davis 23-6202 Evaluating The Impact of COVID-19 Pandemic on Prostate-Specific Antigen Testing in a North American Population: a health system-wide analysis Matt Davis 23-6366 Impact of Age and Race on Prostate-Specific Antigen Testing in Response to the COVID-19 Pandemic Matt Davis 23-6428 Is there a Role for Radical Cystectomy in treating patients with Metastatic Plasmacytoid Bladder Cancer Patients? A Nationwide cohort analysis. Matt Davis 23-6474 Baseline PSA levels in midlife & future development of lethal prostate cancer: A diverse North American cohort analysis Matt Davis 23-6439 Impact of PSA testing pattern on cancer mortality among Black and White men diagnosed with prostate cancer: A large, urban health system cohort analysis Matt Davis 23-6454 Gender Gap in Industry Payments to Urologists Matt Davis 23-8497 Racial disparities in future development of lethal prostate cancer based on PSA levels in midlife Sami Majdalany Robotic Radical Cystectomy, Paravaginal Repair & Intracorporeal Neobladder Sami Majdalany Watt’s In a Name? - The People that Focused Laser Lithotripsy Sami Majdalany Rolling with the Stones - Evolution of Stone Extraction Sami Majdalany Stents and Shockwave Lithotripsy – the Who and the Why: Results from a Statewide Surgical Collaborative (MUSIC) Russell E.N. Becker Daily Ecological Momentary Assessments of Pain and Ability to Work after Ureteroscopy and Stenting Emily Chan Brodowsky Multi-quadrant Robotic Surgery: Adrenalectomy and Paraganglioma Excision Emily Chan Brodowsky Robotic Single Port Pyelolithotomy for a Pelvic Kidney Taylor Malchow 23-7062 Application and survival outcomes of landmark prostate specific antigen screening trial protocols in an urban healthcare system Ivan Rakic 23-8653 Evaluating the role of lymphvascular invasion as an indicator for adverse outcomes for patients with upper tract urothelial carcinoma and its histological subtypes Ivan Rakic 23-8668 The impact of histological subtypes on stage at presentation and overall survival of patients with upper tract urothelial carcinoma: A nationwide cohort analysis Ivan Rakic 23-8607 Is there a racial disparity in the outcomes of patients with non-metastatic upper urothelial carcinoma who are treated surgically? A north american nationwide analysis Sohrab Arora 23-8612 Do saturation prostate biopsies provide additional clinically significant information in patients with MRI identified lesions sampled at the same time? Sohrab Arora 23-8647 Inpatient outcomes of radical nephroureterectomy (NU) for upper tract urothelial cancer (UTUC), with trends in utilization and impact of robotic surgery – National Inpatient Sample (NIS) analysis. Sohrab Arora Outcomes of Precision Prostatectomy procedure for localized prostate cancer, and step-by-step technique of single port transvesical Precision Prostatectomy Sohrab Arora Impact of a novel anterior suspension stitch on return of urinary continence after Robot-assisted Radical Prostatectomy with description of surgical technique Sohrab Arora 23-8594 Inpatient outcomes of simultaneous radical cystectomy and nephroureterectomy in the United States: Retrospective analysis of the National Inpatient Sample Sami Wilder 23-8213 - Using the Multiport da Vinci Xi System as a Training Platform for Single Port Robotic Prostatectomy Sami Wilder 23-8060 - Three-Year Follow-Up for Surveillance of T1 Renal Masses: A MUSIC-KIDNEY Analysis Sami Wilder 23-7800 - Practice and surgeon-level variation in the surgical management of T1a renal masses: Results from a statewide collaborative Sami Wilder 23-6559 - Practice-Level Variation in Opioid-Free Discharge Following Surgery for T1 Renal Masses: A MUSIC-KIDNEY Analysis Ethan Ferguson Extraperitoneal Single-Port Robotic Radical Prostatectomy in over 700 patients: Updated Multi-Institutional Cohort Study from the SPARC Collaboration Ethan Ferguson Single-Port Robotic Radical Prostatectomy in over 1,100 Consecutive Patients from the Multi-Institutional SPARC Collaboration Ethan Ferguson Same-Day Discharge in Single-Port Robotic Radical Prostatectomy: Evaluation of Predictors and Postoperative Outcomes from the Multi-Institutional SPARC collaboration Michael Wang Dueling Active Surveillance: Does Utilization of Active Surveillance for Low Risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses? Mahmoud Hijazi Use of aVirtualTumorBoard to Discuss Renal Masses: Experience from a Quality Improvement Collaborative- no concerns with abstract. Allison May Surveillance of cT1 renal masses is common in patients with CKD Mohit Butaney 23-9548 An Intermediate-term oncological assessment comparing the retzius-sparing RARP to the standard approach in a randomized control cohort Mohit Butaney 23-8318 - Efficiency and User Satisfaction of Single-Use vs Reusable Cystoscopes in a High-Volume Urology Clinic Ajay Gopalakrishna Approach to Robotic-Assisted Radical Nephrectomy in Patients with Severe Morbid Obesity Courtney Yong Nick Corsi Radical Therapy for Low-Risk Upper Tract Urothelial Carcinoma (ROBUUST Collaborative Group) Nick Corsi TESTING THE EXTERNAL VALIDITY OF THE POUT III TRIAL (ADJUVANT PLATNIUM-BASED CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CARCINOMA) IN A NORTH AMERICAN COHORT Gabriele Tuderti ROLE OF PERIOPERATIVE CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CARCINOMA PATIENTS UNDERGOING NEPHROURETERECTOMY: ANALYSIS FROM THE ROBUUST 2.0 REGISTRY Sohail Dhanji HYPERTENSION IS ASSOCIATED WITH WORSENED ONCOLOGICAL SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY Savio Pandolfo PREDICTIVE FACTORS OF COMPLICATIONS AND READMISSIONS IN PATIENTS UNDERGOING MINIMALLY INVASIVE RADICAL NEPHROURETERECTOMY -
AUA VUI 2022 Presentations
Presentor
Presentation
Taylor Malchow MP53-19 PROSTATE SPECIFIC ANTIGEN SCREENING UTILIZATION IN MEN WITH A FAMILY HISTORY OF PROSTATE CANCER AND EXTENDED LIFE EXPECTANCY Mohit Butaney PD25-07 RACIAL DISPARITIES IN SURGICAL TREATMENT OF RENAL MASSES: INITIAL ANALYSIS OF A STATEWIDE REGISTRY Nicholas Corsi PD17-10 PROSTATE SPECIFIC ANTIGEN SCREENING ON A NATIONWIDE LEVEL: FEATURING THE CONTRIBUTION OF RACE AND LIFE EXPECTANCY IN DECISION MAKING Nicholas Corsi MP40-06 ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATHOLOGICAL DOWNSTAGING DURING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP) Margaret Meagher PD15-06 ELEVATED HEMOGLOBIN:CREATININE RATIO IS A NOVEL PREOPERATIVE MARKER FOR WORSENED SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS FROM THE ROBUUST REGISTRY Kevin Hakimi PD58-07 IMPACT OF NODE COUNT ON SURVIVAL OUTCOMES OF LYMPH NODE DISSECTION IN NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY Kevin Hakimi PD58-11 IMPACT OF PRE-OPERATIVE KIDNEY FUNCTION ON SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY Alison Levy V07-03 SOLVING CLINICAL CHALLENGES IN PROSTATECTOMY USING SINGLE-PORT ROBOT SYSTEM: A CASE SERIES Mohit Butaney MP16-03 STONE MANAGEMENT IN THE SOLITARY KIDNEY, ARE WE DOING THINGS DIFFERENTLY? RESULTS FROM A STATEWIDE CLINICAL REGISTRY Mohit Butaney MP47-06 ASSESSING RENAL MASS MANAGEMENT OF PATIENTS WITH INCREASED COMORBIDITIES: RESULTS FROM A STATEWIDE REGISTRY Mohit Butaney PD33-02 EVALUATION OF AN UNCOMPLICATED RECOVERY AFTER NEPHRECTOMY: MUSIC-KIDNEY NOTES (NOTABLE OUTCOMES AND TRACKABLE EVENTS AFTER SURGERY) Mohit Butaney MP16-04 PRACTICE-LEVEL VARIATION IN RATES POSITIVE SURGICAL MARGINS AT PARTIAL NEPHRECTOMY: A MUSIC-KIDNEY ANALYSIS Mohit Butaney MP39-12 REDUCING POST-OPERATIVE EMERGENCY DEPARTMENT VISITS AND READMISSIONS AFTER NEPHRECTOMY: AN INITIAL EVALUATION OF THE MUSIC-KIDNEY REGISTRY Isaac Palma-Zamora MP13-12 PRACTICE PATTERNS AND PREDICTORS OF URINARY STONE MATERIAL SUBMISSION FOR ANALYSIS FOLLOWING URETEROSCOPY: RESULTS FROM A STATEWIDE SURGICAL COLLABORATIVE Marcus Jamil V03-02 EX-VIVO URETEROSCOPY FOR THE TREATMENT OF NEPHROLITHIASIS IN A DECEASED DONOR KIDNEY PRIOR TO TRANSPLANTATION -
AUA VUI 2021 Presentations
Presentor
Presentation
Akshay Sood PD19-11 THE PRECISION PROSTATECTOMY: A NOVEL SURGICAL FORM OF FOCAL THERAPY Deepansh Dalela PD50-03 PSA SCREENING IN US MEN WITH FAMILY HISTORY OF PROSTATE CANCER: A CONTEMPORARY NATIONWIDE SURVEY Mahdi Bazzi PD60-11 HYPOGONADISM PREDICTS HOSPITAL ADMISSION IN MEN WITH COVID-19 INFECTION Deepansh Dalela PD50-04 RACIAL DISPARITIES IN PSA SCREENING IN US MEN WITH FAMILY HISTORY OF PROSTATE CANCER: A CONTEMPORARY NATIONWIDE SURVEY Akshay Sood PD13-03 MORTALITY FROM SECONDARY CANCERS IN MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER: AN INSIGHT INTO PROSTATE CANCER SURVIVORSHIP AT 15-YEARS OF FOLLOW-UP Marcus Jamil MP45-07 RENAL MASS SIZE AND PRESENCE OF SYNCHRONOUS LUNG METASTASIS AT TIME OF DIAGNOSIS: IMPLICATIONS FOR CHEST IMAGING Nicholas Corsi MP16-17 ESTIMATING RECURRENCE-FREE SURVIVAL OF NON-MUSCLE INVASIVE BLADDER CANCER AFTER INTRAVESICAL THERAPY: A CLINICAL-BASED RECURSIVE PARTITION ANALYSIS Emily Chan PD08-08 TIME TO SECOND BIOCHEMICAL RECURRENCE AS A PROGNOSTIC INDICATOR IN POST-PROSTATECTOMY PATIENTS WHO UNDERGO SALVAGE RADIATION THERAPY: AN RTOG 9601 BASED POST-HOC ANALYSIS Deepansh Dalela PD65-02 IMPACT OF PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING INTENSITY ON PROSTATE CANCER DIAGNOSIS IN A RACIALLY DIVERSE HEALTHCARE SYSTEM OVER A 25-YEAR PERIOD Nikola Rakic MP45-19 EVALUATION OF THE UTILITY OF LYMPH-VASCULAR INVASION AS AN INDEPENDENT PROGNOSTIC PREDICTOR OF OVERALL SURVIVAL FOR PATIENTS WITH RENAL CELL CARCINOMA THAT UNDERGO NEPHRECTOMY Marcus Jamil MP30-01 AGE AND RACE ADJUSTED PROSTATE SPECIFIC ANTIGEN VALUES IN MEN WHO PRESENTED TO A SINGLE URBAN TERTIARY HEALTH CARE CENTER: A 25 YEAR EXPERIENCE Deepansh Dalela PD65-05 RACIAL DISPARITY IN PROSTATE CANCER DIAGNOSIS FOR MEN UNDERGOING VARYING INTENSITY OF PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING IN A LARGE, RACIALLY DIVERSE HEALTHCARE SYSTEM Sohrab Arora MP49-09 IMPACT OF PREEXISTING OPIOID-DEPENDENCE ON MORBIDITY, LENGTH OF STAY, AND INPATIENT COST OF UROLOGIC ONCOLOGIC SURGERY Chandler Bronkema PD57-02 NATIONAL CANCER DATABASE ANALYSIS ASSESSING THE IMPACT OF TREATMENT MODALITIES ON SURVIVAL OUTCOMES IN LOCALIZED NEUROENDOCRINE PROSTATE ADENOCARCINOMA Nikola Rakic PD19-12 EXAMINING THE PREDICTIVE ROLE OF LYMPH-VASCULAR INVASION IN PATIENTS WITH VERY HIGH-RISK PROSTATE CANCER Akshay Sood PD34-04 ANTI-ANDROGEN THERAPY OVERCOMES THE TIME-DELAY IN INITIATION OF SALVAGE RADIATION THERAPY AND RESCUES THE ONCOLOGICAL OUTCOMES IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY Akshay Sood MP58-09 RISK OF 30-DAY MORTALITY AND CARDIOPULMONARY COMPLICATIONS IN PATIENTS UNDERGOING EMERGENCY SURGERY WITH PERIOPERATIVE SARS-COV-2 INFECTION Kevin Hakimi PD43-08 OUTCOMES OF LYMPH NODE DISSECTION IN NEPHROURETERECTOMY IN THE TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY
Alexander P. KenigsbergMP48-11 PERIOPERATIVE INTRAVESICAL CHEMOTHERAPY IN MINIMALLY INVASIVE RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: LOW BUT INCREASING UTILIZATION WORLDWIDE Richard C Wu MP30-08 BARRIERS TO ADOPTION AND IMPLEMENTATION OF TRANSPERINEAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA Ajith Dupati MP64-17 PREDICTING LONG-TERM SEXUAL FUNCTION IN POST-RADICAL PROSTATECTOMY PATIENTS BASED ON MRI AND CLINICAL FACTORS: A MULTI-CENTER STUDY Akshay Sood Mortality from Secondary Cancers in Men Treated with Radical Prostatectomy for Prostate Cancer: An Insight into Prostate Cancer Survivorship at 15-Years of Follow-up Nicholas Corsi Recurrence free survival in NMIBC after intra-vesicle therapy: a clinical based recursvie partition analysis Marcus Jamil Urinary Catheter Alleviation Navigator Protocol (Ucanp): Pilot to Reduce Urinary Catheter Reinsertion in Patients in Urinary Retention Craig G Rogers Barriers to adoption and implementation of Transperineal Prostate Biopsy under local anesthesia Alice Semerjian Which patient and tumor factors make radical nephrectomy appropriate treatment for suspicious cT1 renal masses? Zach Prebay Perspectives on the Role of Biopsy for Management of T1 Renal Masses: Results from Two Quality Improvement Collaboratives. Mohit Butaney Initial Management of Indeterminate Renal Masses in a Statewide Collaborative:a MUSIC-KIDNEY analysis Sara Documentation of Nephrometry Scores for cT1a Renal Masses Correlates with Avoidance of Radical Nephrectomy Across the MUSIC-KIDNEY Statewide QI Collaborative Natalija Kovacevic Disparity in Female Pelvic Examinations in the Evaluation of Lower Urinary Tract Symptoms Ajith Dupati Predicting Long-term Sexual Function in Post-Radical Prostatectomy Patients Based on MRI and Clinical Factors: A Multi-center Study -
AUA VUI 2020 Presentations
Presentor
Presentation
Eugune Cone PD16-09 ABIRATERONE IS ASSOCIATED WITH HIGHER ODDS OF CARDIAC COMPLICATIONS COMPARED TO ENZALUTAMIDE Deepansh Dalela PD38-01 VALIDITY OF PSA SCREENING TRIALS IN A 'REAL WORLD' SETTING: A NATIONWIDE SURVEY ANALYSIS Marcus Jamil MP50-10 LONG-TERM RISK OF RECURRENCE IN SURGICALLY TREATED RENAL CELL CARCINOMA: A POST-HOC ANALYSIS OF THE EASTERN COOPERATIVE ONCOLOGY GROUP - AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK (ECOG-ACRIN) E2805 TRIAL COHORT Natalija Kovacevic MP79-08 IDENTIFYING PATIENTS THAT MAY BENEFIT FROM ADDITION OF BICALUTAMIDE TO SALVAGE RADIATION THERAPY IN THE SETTING OF BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY Chandler Bronkema MP67-18 IMPACT OF TREATMENT MODALITY ON OVERALL SURVIVAL IN LOCALIZED DUCTAL PROSTATE ADENOCARCINOMA: A NATIONAL CANCER DATABASE ANALYSIS Marcus Jamil MP62-03 IMPACT OF LYMPHOVASCULAR INVASION ON OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY STRATIFIED BY PATHOLOGICAL TUMOR STAGE Deepansh Dalela PD48-09 PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING UTILIZATION HAS SIGNIFICANTLY DROPPED OVER THE LAST TWO DECADES, EVEN IN MEN WITH EXTENDED LIFE-EXPECTANCY: A NATIONWIDE ANALYSIS Chandler Bronkema PD13-05 NATIONAL CANCER DATABASE COMPREHENSIVE SURVIVAL ANALYSIS OF NONMETASTATIC RARE HISTOLOGICAL VARIANT PROSTATE ADENOCARCINOMA Sohrab Arora MP21-01 IMPACT OF PREEXISTING OPIOID DEPENDENCE ON MORBIDITY, LENGTH OF STAY, AND INPATIENT COST OF SURGERY FOR KIDNEY CANCER Akshay Sood MP79-09 ANTI-ANDROGEN THERAPY OVERCOMES THE TIME-DELAY IN INITIATION OF SALVAGE RADIATION THERAPY AND RESCUES ONCOLOGICAL OUTCOMES IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY Isaac Palma-Zamora MP81-07 COMPARISON OF SYSTEMATIC 12-CORE PROSTATE BIOPSY AND MAGNETIC RESONANCE IMAGING FUSION PROSTATE BIOPSY TO THE FINAL SURGICAL PATHOLOGY Akshay Sood PD15-12 USE OF ULTRA-LOW DOSE COMPUTED TOMOGRAPHY VERSUS ABDOMINAL PLAIN FILM FOR ASSESSMENT OF STONE-FREE RATES AFTER SHOCK-WAVE LITHOTRIPSY (SWL): IMPLICATIONS ON SUBSEQUENT EMERGENCY ROOM VISITS, SURGICAL PROCEDURES AND COST-EFFECTIVENESS Ali A Dabaja MP12-15 ADDITION OF PREOPERATIVE PROSTATE MRI VARIABLES IMPROVES PREDICTION OF EARLY SOCIAL CONTINENCE AFTER RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL ANALYSIS Alexander P Cole MP79-10 A SMARTPHONE-BASED MOBILE HEALTH APP TO ADDRESS THE ADVERSE EFFECTS OF ANDROGEN DEPRIVATION THERAPY IN MEN WITH PROSTATE CANCER -
AUA VUI 2019 Presentations
Presentor
Presentation
Firas Abdollah MP72-06 EVALUATING THE IMPACT OF LEAD-TIME BIAS ON THE OBSERVED EFFICACY OF EARLY SALVAGE RADIATION THERAPY IN PROSTATE CANCER: A POST-HOC ANALYSIS OF THE RTOG 9601 TRIAL Sohrab Arora PD25-12 INPATIENT MORBIDITY AND COST OF CYTOREDUCTIVE RADICAL PROSTATECTOMY IN THE UNITED STATES Akshay Sood PD15-06 RATES AND PATTERNS OF METASTASES IN PATIENTS WITH NODE-NEGATIVE PROSTATE CANCER AT RADICAL PROSTATECTOMY THAT EXPERIENCE PSA FAILURE: POST-HOC ANALYSIS OF RTOG 9601 TRIAL DATA Audrey Fotouhi MP60-01 THE CHANGING FACE OF SURGICALLY TREATED LOW-RISK PROSTATE CANCER: A NATIONAL CANCER DATABASE ANALYSIS Nikola Rakic MP72-11 PERSISTENT UNDER-UTILIZATION OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH ADVERSE PATHOLOGICAL FEATURES AT RADICAL PROSTATECTOMY (RP): A NATIONAL CANCER DATABASE (NCDB) ANALYSIS Sohrab Arora MP77-17 ADMISSION RATES, HEALTHCARE UTILIZATION, AND ECONOMIC BURDEN OF RADIATION CYSTITIS (RC) IN THE UNITED STATES Hernan Lescay MP54-11 PELVIC LYMPH NODE DISSECTION DURING ROBOTIC PROSTATECTOMY IN THE MUSIC COLLABORATIVE Sohrab Arora MP41-17 RARE HISTOLOGICAL VARIANTS OF PROSTATE ADENOCARCINOMA (PCA): A NATIONAL CANCER DATABASE (NCDB) ANALYSIS Sohrab Arora PD03-07 TESTING THE EXTERNAL VALIDITY OF CARMENA TRIAL COMPARING SUNITINIB ALONE OR AFTER NEPHRECTOMY IN METASTATIC RENAL-CELL CARCINOMA Lee Baumgarten MP72-03 IMPACT OF TIMING ON RADIATION THERAPY ADVERSE EVENTS FOLLOWING RADICAL PROSTATECTOMY: A SECONDARY ANALYSIS OF THE RTOG 9601 COHORT Wei Shen Tan MP66-05 VARIATION IN POSITIVE SURGICAL MARGIN STATUS FOLLOWING RADICAL PROSTATECTOMY FOR PT2 PROSTATE CANCER Sohrab Arora PD41-02 FEASIBILITY OF OMITTING OUTER (CORTICAL) RENORRHAPHY DURING ROBOTIC PARTIAL NEPHRECTOMY - A MULTI-INSTITUTIONAL ANALYSIS Zade Roumayah MP13-17 PREVALENCE OF CRITERIA FOR GENETIC TESTING ACCORDING TO THE NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN A CONTEMPORARY COHORT OF POST PROSTATECTOMY MEN WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER: THE HENRY FORD HEALTH SYSTEM EXPERIENCE Moustafa Deebaja MP09-20 THE DISTRIBUTION OF COMEDONECROSIS IN INTRADUCTAL VERSUS INVASIVE PROSTATE CANCER: ANALYSIS FROM A LARGE SINGLE CENTER PROSTATECTOMY SERIES Shaheen Alanee MP09-09 THE ASSOCIATION BETWEEN PATHOLOGIC FEATURES OF LYMPH NODE METASTASIS IDENTIFIED AFTER PROSTATECTOMY AND THE RISK OF BIOCHEMICAL RECURRENCE: A STUDY OF 280 CASES Grace Yaguchi MP13-03 NEED FOR SYSTEMIC 12-CORE BIOPSY CONCURRENT WITH MRI TARGETED BIOPSY OF PI-RADS 4 AND PI-RADS 5 LESIONS Ahmed A Hussein MP26-11 TEN-YEAR ONCOLOGIC OUTCOMES FOLLOWING ROBOT ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM -
AUA VUI 2018 Presentations
Presentor
Presentation
Sohrab Arora MP48-18 WHAT IS THE HOSPITAL VOLUME THRESHOLD TO OPTIMIZE MAJOR INPATIENT COMPLICATION RATE AFTER ROBOTIC PARTIAL NEPHRECTOMY? Akshay Sood PD25-03 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA VERSUS OPEN KIDNEY TRANSPLANTATION FOR PATIENTS WITH END STAGE RENAL DISEASE: A TWO-ARM STUDY (IDEAL PHASE 2B) Akshay Sood MP87-16 EFFECT OF RACE ON THE RISK OF METASTASIS AND MORTALITY IN PATIENTS EXPERIENCING EARLY BIOCHEMICAL RECURRENCE FOLLOWING ROBOTIC RADICAL PROSTATECTOMY Mustafa Deebajah MP14-14 PROPENSITY SCORE MATCHED STUDY TO EXAMINE THE EFFECT OF RACE ON THE NUMBER OF LESIONS SUSPICIOUS FOR PROSTATE CANCER DETECTED THROUGH MAGNETIC RESONANCE IMAGING OF THE PROSTATE Richard Thompson MP14-16 THE CHARACTERISTICS OF PROSTATE CANCER ON FINAL PATHOLOGY IN MEN UNDERGO RADICAL PROSTATECTOMY WITH A NEGATIVE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING Firas Abdollah MP42-12 TESTING THE EXTERNAL VALIDITY OF EORTC 30904 COMPARING OVERALL SURVIVAL AFTER RADICAL NEPHRECTOMY VS NEPHRON SPARING SURGERY IN CONTEMPORARY NORTH AMERICAN PATIENTS WITH RENAL CELL CANCER Alex Borchert MP67-13 INCIDENCE OF PEYRONIE'S DISEASE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY IN MEN WITH POST-OPERATIVE SUPRAPUBIC CATHETERS AND NO URETHRAL FOLEY CATHETERS Firas Abdollah MP22-05 TESTING THE IMPACT OF ADJUVANT RADIOTHERAPY (ART) AFTER RADICAL PROSTATECTOMY (RP) ON OVERALL MORTALITY (OM) IN PROSTATE CANCER PATIENTS WITH PATHOLOGICALLY NODE POSITIVE DISEASE: A NATIONWIDE ANALYSIS Sean A Fletcher MP53-01 CONTEMPORARY NATIONAL TRENDS IN LOCALIZED PROSTATE CANCER RISK PROFILE AT DIAGNOSIS Tyler R McClintock PD38-06 CONTEMPORARY TRENDS IN UTILIZATION OF RADICAL PROSTATECTOMY Firas Abdollah MP05-05 ASSESSING THE EXTERNAL VALIDITY OF THE UPDATED PROSTATE CANCER(PCA) INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT) Tyler R McClintock MP13-19 TESTOSTERONE REPLACEMENT THERAPY IS ASSOCIATED WITH INCREASED INCIDENCE OF UROLITHIASIS Alexander P Cole MP41-11 IMPACT OF HIGH VOLUME SURGICAL CARE ON MEDIAN OVERALL SURVIVAL FOR LOCALIZED BLADDER CANCER Daniel Pucheril MP77-18 IMPACT OF SEXUAL ORIENTATION ON CONTEMPORARY RATES OF PROSTATE CANCER SCREENING MP82-02 SHARED DECISION MAKING FOR PROSTATE CANCER SCREENING: REALITY OR FARCE? Daniel Pucheril MP82-03 IMPACT OF LATE MEDICAID EXPANSION ON PROSTATE CANCER SCREENING Philipp Gild PD11-09 RACIAL DISPARITIES IN QUALITY OF CARE AND OVERALL SURVIVAL AMONG MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: A NATIONAL CANCER DATABASE ANALYSIS Nicholas Von Landenberg MP11-10 NEOADJUVANT ANDROGEN DEPRIVATION THERAPY PRIOR TO RADICAL PROSTATECTOMY: RECENT TRENDS IN UTILIZATION AND ASSOCIATION WITH POSTOPERATIVE SURGICAL MARGIN STATUS Sean A Fletcher Marco Bandini MP17-07 INCREASING RATE OF NON-INTERVENTIONAL TREATMENT MANAGEMENT IN LOCALIZED PROSTATE CANCER CANDIDATES FOR ACTIVE SURVEILLANCE Nazareno Suardi MP21-09 WHO DIES FROM PROSTATE CANCER? A COMPREHENSIVE ANALYSIS OF A LARGE SERIES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH LONG-TERM FOLLOW-UP Michele Marchioni PD07-06 COMPARISON OF PARTIAL VS. RADICAL NEPHRECTOMY EFFECT ON OTHER CAUSE MORTALITY, CANCER SPECIFIC MORTALITY AND 30-DAY MORTALITY IN PATIENTS OLDER THAN 75 YEARS Giorgio Gandaglia MP53-17 WHERE DO WE MISS EXTRACAPSULAR EXTENSION AT MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE? Emanuele Zaffuto PD38-01 WHICH PATIENTS WITH LOW-RISK PROSTATE CANCER ARE STILL RECEIVING RADICAL PROSTATECTOMY? IMPACT OF PATIENT SELECTION ON INVERSE STAGE MIGRATION AT TWO TERTIARY REFERRAL CENTERS -
AUA VUI 2017 Presentations
Presentor
Presentation
Mani Menon MP97-04 URINARY CONTINENCE, SEXUAL FUNCTION AND BIOCHEMICAL RECURRENCE 12 MONTHS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A RANDOMIZED CONTROLLED STUDY COMPARING THE ‘BOCCIARDI’ AND ‘MENON’ TECHNIQUES Sohrab Arora MP06-05 LEARNING CURVE OF A NEW SURGICAL PROCEDURE: EXPERIENCE FROM A NEW CENTER ADOPTING ROBOTIC KIDNEY TRANSPLANT. Gregory Auffenberg PD18-02 MEASURING TO IMPROVE: PATIENT REPORTED OUTCOMES DURING THE FIRST YEAR AFTER PROSTATECTOMY IN A STATEWIDE COLLABORATIVE Jesse Sammon PD32-05 PROSTATE CANCER SCREENING: EFFECT OF EARLY MEDICAID EXPANSION Daniel Pucheril MP69-01 ANTIMUSCARINIC USE IN THE ELDERLY: A POISONED APPLE? Deepansh Dalela PD03-06 CONTEMPORARY TRENDS IN INCIDENCE OF METASTATIC PROSTATE CANCER AMONG US MEN: RESULTS FROM NATIONWIDE ANALYSES Stephen Ryan MP04-20 THE ASSOCIATION BETWEEN MORTALITY AND DISTANCE TO TREATMENT FACILITY IN PATIENTS WITH INVASIVE BLADDER CANCER Jesse Sammon PD58-12 PSA SCREENING AT THE INTERSECTION OF POLITICS AND POLICY Naveen Kachroo MP92-07 TAKE ‘NOTES’: IDENTIFYING DRIVERS OF 30 DAY READMISSION AFTER RADICAL PROSTATECTOMY Malte W. Vetterlein PD18-07 THE IMPACT OF TRAVEL DISTANCE TO THE TREATMENT FACILITY ON OVERALL MORTALITY IN PROSTATE CANCER PATIENTS: EVIDENCE FROM THE NATIONAL CANCER DATA BASE Haider Rahbar PD43-11 LACK OF SUSTAINABLE RESPONSE TO THE 2012 UNITED STATES PREVENTIVE SERVICES TASK FORCE (USPSTF) RECOMMENDATION AGAINST PROSTATE CANCER (PCA) SCREENING Tarun Jindal PD51-05 SURVIVAL ASSOCIATED WITH RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER: A CONTEMPORARY, NATIONWIDE OBSERVATIONAL ANALYSIS Björn Löppenberg PD47-08 VARIATION AND TRENDS IN PROSTATE CANCER CARE AT COMMISSION ON CANCER DESIGNATED FACILITIES Philipp Gild MP28-08 REFUSAL OF PROSTATE-SPECIFIC ANTIGEN TESTING IN THE UNITED STATES Thomas Seisen PD57-03 ASSESSMENT OF THE ECOLOGICAL ASSOCIATION BETWEEN TOBACCO SMOKING EXPOSURE AND BLADDER CANCER INCIDENCE OVER THE PAST HALF-CENTURY IN THE UNITED STATES Deepansh Dalela PD72-02 GENOMIC CLASSIFIER AUGMENTS THE ROLE OF PATHOLOGICAL FEATURES IN IDENTIFYING OPTIMAL CANDIDATES FOR ADJUVANT RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER: DEVELOPMENT AND INTERNAL VALIDATION OF A MULTIVARIABLE PROGNOSTIC MODEL Deepansh Dalela PD15-04 A RANDOMIZED CONTROLLED TRIAL EXAMINING THE IMPACT OF THE RETZIUS- SPARING APPROACH ON EARLY URINARY CONTINENCE RECOVERY AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY Nicholas Von Landenberg MP22-18 CONTEMPORARY INCIDENCE AND EPIDEMIOLOGIC TRENDS OF BRAIN METASTASES AT RENAL CELL CARCINOMA DIAGNOSIS Thomas Seisen MP53-18 EFFICACY OF LOCAL TREATMENT IN PROSTATE CANCER PATIENTS WITH CLINICALLY PELVIC LYMPH NODE-POSITIVE DISEASE AT INITIAL DIAGNOSIS Thomas Seisen PD62-02 ADJUVANT CHEMOTHERAPY VS. OBSERVATION FOLLOWING RADICAL CYSTECTOMY FOR PT3-4 AND/OR PN+ UROTHELIAL CARCINOMA OF THE BLADDER PREVIOUSLY TREATED WITH NEOADJUVANT CHEMOTHERAPY Malte W. Vetterlein MP34-11 NEOADJUVANT CHEMOTHERAPY PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY Nawar Hanna PD67-09 COMPARATIVE EFFECTIVNESS OF ROBOT-ASSISTED VS. OPEN RADICAL CYSTECTOMY Julian Hanske MP91-04 ADVERSE EFFECTS OF TESTOSTERONE REPLACEMENT THERAPY FOR MEN, A MATCHED COHORT STUDY Björn Löppenberg PD28-06 VARIATION IN THE USE OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER David Friedlander PD10-10 RACIAL DISPARITIES IN DELIVERING DEFINITIVE THERAPY FOR INTERMEDIATE-HIGH RISK LOCALIZED PROSTATE CANCER: THE IMPACT OF FACILITY FEATURES AND SOCIOECONOMIC CHARACTERISTICS Christian P Meyer PD27-11 COMPARATIVE EFFECTIVENESS OF TRANSURETHRAL RESECTION TECHNIQUES FOR BENIGN PROSTATIC HYPERPLASIA – ANALYSIS OF AN ALL PAYER INPATIENT DISCHARGE DATABASE Christian P Meyer MP55-17 ASSESSMENT OF METASTASECTOMY COMPLICATIONS IN RENAL CELL CARCINOMA Thomas Seisen PD62-01 COMPARATIVE EFFECTIVENESS OF SELECTIVE ADJUVANT VERSUS SYSTEMATIC NEOADJUVANT CHEMOTHERAPY-BASED STRATEGY FOR MUSCLE- INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER Malte W. Vetterlein MP34-19 EFFECT OF HISTOLOGICAL VARIANTS ON THE OUTCOMES OF RADICAL CYSTECTOMY FOR NON-METASTATIC MUSCLE-INVASIVE URINARY BLADDER CANCER Michael E Zavaski PD05-11 CONTEMPORARY PERCEPTIONS OF HUMAN PAPILLOMAVIRUS AND PENILE CANCER – PERSPECTIVES FROM A NATIONAL SURVEY Thomas Seisen PD62-12 COMPARATIVE EFFECTIVENESS OF TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR LOCALIZED MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER Paul May MP92-05 CALCULATING SURGICAL TIME FOR ROBOT-ASSISTED RADICAL CYSTECTOMY BASED ON PATIENT RELATED METRICS & INSTITUTIONAL EXPERIENCE: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM -
AUA VUI 2016 Presentations<td">MP37-02 INFORMED DECISION-MAKING FOR PROSTATE-SPECIFIC ANTIGEN SCREENING </td">
Presentor
Presentation
Naveen Kachroo PD03-10 APPLICABILITY OF EPSTEIN’S CRITERIA FOR ACTIVE SURVEILLANCE IN A CONTEMPORARY US COHORT UNDERGOING ROBOTIC PROSTATECTOMY Akshay Sood MP29-07 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: RESULTS FROM A PROSPECTIVE TWO-ARM NON-RANDOMIZED CONTROLLED TRIAL (IDEAL PHASE 2B) Firas Abdollah PD43-12 URINARY CONTINENCE OUTCOMES AFTER RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A PROSPECTIVE, NON-RANDOMIZED, IDEAL STAGE 2B (EXPLORATION) STUDY. Mohsin Jamal MP79-12 CLINICAL SIGNIFICANCE OF PERCENTAGE OF GLEASON PATTERN 4 IN GLEASON SCORE 7 PROSTATE CANCER AT RADICAL PROSTATECTOMY Akshay Sood MP80-06 INTRAOPERATIVE BIMANUAL EXAMINATION AND FROZEN-SECTION ANALYSIS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A NOVEL TECHNIQUE FOR REDUCING POSITIVE SURGICAL MARGINS Firas Abdollah PD15-01 THE IMPACT OF 2011 UNITED STATES PREVENTIVE SERVICES TASK FORCE PANEL UPDATE ON PSA SCREENING PRACTICE: A NATIONWIDE, AND STATE-BY-STATE LEVEL ANALYSES. Firas Abdollah MP21-05 TEMPORAL TRENDS IN PROSTATE CANCER RISK GROUP STRATIFICATION FOLLOWING THE 2008 UNITED STATES PREVENTIVE SERVICES TASK FORCE RECOMMENDATIONS Jesse Sammon MP21-08 DETERMINANTS OF PROSTATE SPECIFIC ANTIGEN SCREENING AMONG BLACK MEN IN THE UNITED STATES IN THE CONTEMPORARY ERA Jesse Sammon MP21-11 AGE DEPENDENT VARIATION IN THE EFFECT OF PHYSICIAN RECOMMENDATIONS TO UNDERGO PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING FOLLOWING THE UNITED STATES PREVENTIVE SERVICES TASK FORCE 2012 STATEMENT AGAINST PSA SCREENING. Hanhan Li MP25-08 DETERMINANTS OF PROSTATE CANCER SCREENING IN ASIAN AMERICANS Deepansh Dalela PD37-01 CONTEMPORARY TRENDS IN TREATMENT PATTERNS FOR MEN DIAGNOSED WITH CLINICALLY LOCALIZED PROSTATE CANCER Firas Abdollah PD37-03 IS THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL REFLECTIVE OF THE CONTEMPORARY US POPULATION DIAGNOSED WITH PROSTATE CANCER? RESULTS FROM THE NATIONAL CANCER DATABASE 2004-2011 Björn Löppenberg MP65-20 SLING PROCEDURES FOR FEMALE STRESS INCONTINENCE: DOES SURGICAL SPECIALTY MATTER? Deepansh Dalela MP39-14 IMPACT OF THE 2012 UNITED STATES PREVENTIVE SERVICES TASK FORCE RECOMMENDATION AGAINST PROSTATE SPECIFIC ANTIGEN SCREENING ON PROSTATE CANCER RISK GROUP STRATIFICATION Björn Löppenberg MP50-12 THE IMPACT OF LOCAL TREATMENT ON OVERALL MORTALITY IN PATIENTS DIAGNOSED WITH PRIMARY METASTATIC PROSTATE CANCER Christian P Meyer MP21-10 THE IMPACT OF MEDICARE ELIGIBILITY ON PROSTATE CANCER SCREENING BEHAVIORS Alexander P Cole PI-04 SURGEON AND HOSPITAL VARIATION IN THE COSTS OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN THE UNITED STATES Jeffrey Leow PD39-07 SURGEON VARIATION IN THE COSTS OF RADICAL CYSTECTOMY Nawar Hanna Christian P Meyer MP63-06 RACIAL DISPARITIES IN QUALITY METRICS OF MUSCLE INVASIVE BLADDER CANCER Michael E Zavaski PD15-03 DIFFERENCES IN PROSTATE SPECIFIC ANTIGEN TESTING AMONG UROLOGISTS AND PRIMARY CARE PROVIDERS IN THE UNITED STATES FOLLOWING THE 2011 USPSTF RECOMMENDATIONS Christian P Meyer MP69-11 MINIMALLY INVASIVE VS. OPEN RADICAL PROSTATECTOMY: AN ANALYSIS OF 30-DAY POSTOPERATIVE COMPLICATIONS, UNPLANNED READMISSIONS, AND MORTALITY Firas Abdollah MP80-20 LONG-TERM FUNCTIONAL OUTCOMES OF PROSTATE CANCER PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY Christian P Meyer PD04-05 TRENDS OF METASTASECTOMY FOR METASTATIC RENAL CELL CARCINOMA AND THEIR IMPACT ON OVERALL SURVIVAL Firas Abdollah MP80-02 LATE RECOVERY OF ERECTILE FUNCTION IN MEN TREATED WITH ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A NOVEL NOMOGRAM DEVELOPMENT AND VALIDATION Ahmed A Hussein MP06-09 ASSESSMENT OF PATIENT CENTERED, CANCER SPECIFIC QUALITY METRICS IN ROBOT-ASSISTED RADICAL CYSTECTOMY: HOW DID WE PERFORM? -
AUA VUI 2015 Presentations
Presentor
Presentation
Vijayalakshmi Thamilselvan MP46-20 CARMUSTINE AND SELENITE COMBINATION THERAPY EFFECTIVELY INHIBITS CASTRATION RESISTANT PROSTATE CANCER IN PRECLINICAL MODELS Akshay Sood MP79-14 MINIMALLY INVASIVE KIDNEY TRANSPLANTATION: PERIOPERATIVE CONSIDERATIONS AND KEY 6-MONTH OUTCOMES Alexander P Cole PD31-06 TEMPORAL TRENDS AND PREDICTORS OF THE RECEIPT OF ADEQUATE LYMPHADENECTOMY AT RADICAL CYSTECTOMY FOR BLADDER CANCER Jesse Sammon PD6-12 DIMINISHING RETURNS OF ROBOTIC DIFFUSION: COMPLICATIONS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY Jesse Sammon PD38-01 HETEROGENEITY OF RECOMMENDED PSA SCREENING PRACTICES IN MEN AGED 55-69 IN THE UNITED STATES Akshay Sood MP79-04 NATIONAL TRENDS AND RACIAL DISPARITIES IN LIVING KIDNEY DONATION: ANALYSIS OF THE UNITED NETWORK OF ORGAN SHARING 1998-2011 Jesse Sammon MP77-13 DEFICIENCIES IN PSA SCREENING PRACTICES IN BLACK MEN AGED 55-69 IN THE UNITED STATES Akshay Sood PD13-03 ROBOTIC ANATROPHIC NEPHROLITHOTOMY: IDEA, DEVELOPMENT, EXPLORATION, ASSESSMENT AND LONG-TERM MONITORING (IDEAL) PHASE 0 STUDY Laura Favazza MP53-13 IS DOMINANT TUMOR NODULE SIZE A SIGNIFICANT PREDICTOR OF ADVERSE OUTCOME IN PROSTATE CANCER? A STUDY OF 487 WHOLE MOUNT RADICAL PROSTATECTOMY CASES. Jesse Sammon MP87-05 INCREASING USE OF HOSPICE SERVICES FOR METASTATIC PROSTATE CANCER MODERATES THE ECONOMIC BURDEN OF HOSPITAL ADMISSIONS FOR METASTATIC PROSTATE CANCER Jesse Sammon MP64-13 HEALTHCARE-ASSOCIATED INFECTIONS FOLLOWING CYSTECTOMY: ROOM FOR IMPROVEMENT Jesse Sammon MP73-19 PRIMARY ANDROGEN DEPRIVATION THERAPY INCREASES ALL CAUSE MORTALITY IN POPULATIONS MATCHED BY COMORBIDITY ADJUSTED LIFE EXPECTANCY AND DISEASE RISK Firas Abdollah MP78-19 PREDICTING PATHOLOGIC OUTCOMES IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PREOPERATIVE NOMOGRAM Akshay Sood MP9-14 POSTOPERATIVE SEPSIS PREDICTION IN PATIENTS UNDERGOING MAJOR CANCER SURGERY Daniel Pucheril MP77-10 THE INFLUENCE OF PHYSICIAN RECOMMENDATION ON PSA SCREENING Firas Abdollah MP87-14 ADJUVANT RADIOTHERAPY IN PROSTATE CANCER PATIENTS TREATED WITH SURGERY: THE IMPACT OF AGE AND TUMOR CHARACTERISTICS Akshay Sood MP65-19 AN EVALUATION OF THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY Christian P Meyer MP67-09 PREDICTORS OF WOUND DEHISCENCE IN A PROSPECTIVE DATASET OF 2,556 CYSTECTOMIES Marianne Schmid MP24-20 CAUSES OF HOSPITAL READMISSIONS AFTER UROLOGIC CANCER SURGERY Jeffrey Leow MP32-08 READMISSIONS AFTER MAJOR UROLOGIC CANCER SURGERY Akshay Sood MP54-07 INCIDENCE, ADMISSION RATES AND ECONOMIC BURDEN OF PEDIATRIC EMERGENCY DEPARTMENT VISITS FOR URINARY TRACT INFECTION Firas Abdollah MP60-01 PREVALENCE OF NON-RECOMMENDED SCREENING FOR PROSTATE CANCER AND BREAST CANCER IN THE UNITED STATES Christian P Meyer MP67-05 THE IMPACT OF PREOPERATIVE HYPOALBUMINEMIA ON PERIOPERATIVE OUTCOMES AFTER RADICAL CYSTECTOMY IN 1,262 PATIENTS Daniel Pucheril MP77-12 CONTEMPORARY PATTERNS OF SELF-REPORTED PSA SCREENING IN U.S. VETERANS Nicola Fossati MP82-07 DOES LOCAL TREATMENT OF THE PRIMARY TUMOR IMPROVE SURVIVAL OF METASTATIC PROSTATE CANCER PATIENTS? RESULTS FROM A POPULATION-BASED STUDY. James O Peabody PD30-05 WISDOM OF THE CROWDS: USE OF CROWDSOURCING TO ASSESS SURGICAL SKILL OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN A STATEWIDE SURGICAL COLLABORATIVE Marianne Schmid PD30-09 THE EFFECT OF ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER ON CARDIOVASCULAR MORBIDITY ACCORDING TO LIFE EXPECTANCY Akshay Sood ;MP59-03 AN EVALUATION OF THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING NEPHRECTOMY Firas Abdollah MP73-11 ANDROGEN DEPRIVATION THERAPY AND INCREASED NON-CANCER MORTALITY IN PROSTATE CANCER PATIENTS: ANALYSIS OF THE NUMBER NEEDED TO TREAT Nicola Fossati MP24-06 THE IMPACT OF INSURANCE STATUS ON TUMOR CHARACTERISTICS AND TREATMENT SELECTION IN CONTEMPORARY PROSTATE CANCER PATIENTS Marianne Schmid PD30-12 RACIAL DISPARITIES IN THE SURGICAL CARE OF LOCALIZED PROSTATE CANCER Akshay Sood MP9-08 IMPACT OF SMOKING ON PERIOPERATIVE OUTCOMES AFTER MAJOR UROLOGIC SURGERY Nicola Fossati PD30-03 PREDICTING UNFAVORABLE PROSTATE CANCER IN ACTIVE SURVEILLANCE CANDIDATES TREATED WITH RADICAL PROSTATECTOMY: A POPULATION-BASED STUDY Nicola Fossati MP78-01 CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY. Firas Abdollah MP4-14 LONG-TERM CANCER CONTROL OUTCOMES IN PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI-INSTITUTIONAL DATABASE ANALYSIS. Firas Abdollah PD30-08 CANCER-CONTROL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI-INSTITUTIONAL DATABASE ANALYSIS Firas Abdollah MP62-01 FUNCTIONAL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) Firas Abdollah MP82-16 LONG-TERM CLINICAL RECURRENCE RATE IN PROSTATE CANCER (PCA) PATIENTS WITH ADVERSE PATHOLOGICAL CHARACTERISTICS AT ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) Firas Abdollah MP82-17 ONCOLOGICAL OUTCOMES IN PN1 PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) -
AUA VUI 2014 Presentations
Presentor
Presentation
Khurshid Ghani V11-01 RETROPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY: A STEP-BY-STEP GUIDE Vijayalakshmi Thamilselvan MP20-14 UNCOUPLED ENDOTHELIAL NITRIC OXIDE SYNTHASE CONTRIBUTES TO OXALATE-INDUCED OXIDATIVE CELL INJURY IN RENAL EPITHELIAL CELLS: EFFECT OF ANTIOXIDANTS Craig G Rogers V7-12 EVOLUTION OF REGIONAL HYPOTHERMIA IN ROBOTIC KIDNEY SURGERY Mahendra Bhandari V7-06 RECIPIENT ROBOT ASSISTED KIDNEY TRANSPLANT LEARNING STEPS: FRAME-BY-FRAME VIDEO ANALYSIS Akshay Sood PD30-02 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: RESULTS FROM A PROSPECTIVE TWO-ARM NON-RANDOMIZED CONTROLLED TRIAL (IDEAL PHASE 2B) Wooju Jeong MP72-10 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: EVOLUTION OF A NOVEL PROCEDURE UTILIZING THE IDEAL GUIDELINES (IDEAL PHASE 0 AND 1) Wooju Jeong V9-03 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: A STEP-BY-STEP DESCRIPTION OF THE VUI-MEDANTA TECHNIQUE (IDEAL PHASE 2A) Briony Varda PD7-06 NATIONAL RATES AND RISK FACTORS FOR STENT FAILURE IN PATIENTS WITH OBSTRUCTED, INFECTED UPPER TRACT STONES Tudor Borza MP2-16 MORBIDITY AND MORTALITY AFTER BENIGN PROSTATIC HYPERPLASIA SURGERY: DATA FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM Syed Johar Raza MP61-10 LONG-TERM SURVIVAL OUTCOMES OF ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM Abd-El-Rahman PD5-11 TRENDS AND OUTCOMES IN PEDIATRIC SICKLE CELL-ASSOCIATED PRIAPISM Ramesh Kumar MP54-07 ROBOTIC PARTIAL NEPHRECTOMY IN PATIENTS WITH BASELINE CHRONIC KIDNEY DISEASE: A MULTICENTER PROPENSITY SCORE MATCHED ANALYSIS Giorgio Gandaglia MP51-19 COMPARATIVE EFFECTIVENESS OF ROBOTIC-ASSISTED AND OPEN RADICAL PROSTATECTOMY IN THE “POST-LEARNING CURVE” ERA Ariella A Friedman MP3-09 NATIONAL TRENDS AND DISPARITIES IN THE UTILIZATION OF INPATIENT HYPOSPADIAS SURGERY -
AUA VUI 2013 Presentations
Presentor
Presentation
Vijayalakshmi Thamilselvan 2086 OXALATE-INDUCED NADPH OXIDASE ACTIVATION IN RENAL EPITHELIAL CELLS: ROLE OF UPSTREAM MEDIATORS Craig G Rogers V1077 INTRACORPOREAL COOLING AND EXTRACTION TECHNIQUE OF ROBOTIC PARTIAL NEPHRECTOMY: RECAPITULATING THE OPEN APPROACH Khurshid R Ghani 1305 OUTCOMES FOR OPEN AND MINIMALLY INVASIVE PARTIAL NEPHRECTOMY SINCE THE INTRODUCTION OF ROBOTIC PARTIAL NEPHRECTOMY: RESULTS FROM THE NATIONWIDE INPATIENT SAMPLE Wooju Jeong 845 BIMANUAL EXAMINATION OF RETRIEVED SPECIMEN DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A NOVEL TECHNIQUE FOR REDUCING THE POSTIVE SURGICAL MARGIN Syed Johar Raza 1564 CONSTRUCT VALIDATION OF THE FUNDAMENTAL SKILLS OF ROBOTIC SURGERY (FSRS) CURRICULUM Ashirwad Chowriappa 886 DEVELOPMENT & VALIDATION OF A COMPOSITE GRADING & SCORING SYSTEM FOR ROBOT-ASSISTED SURGICAL TRAINING — THE ROBOTIC SKILLS ASSESSMENT SCALE Wooju Jeong V2156 BIMANUAL EXAMINATION OF RETRIEVED SPECIMEN AND REGIONAL HYPOTHERMIA DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY Khurshid R Ghani 69 THE BURDEN OF HEMATURIA IN THE UNITED STATES: ESTIMATES FROM THE NATIONWIDE EMERGENCY DEPARTMENT SAMPLE Jesse Sammon 362 ROBOT-ASSISTED VS. OPEN RADICAL PROSTATECTOMY: A COMPARISON OF OUTCOMES ACROSS PROCEDURE TYPE AND VOLUME QUARTILE Shyam Sukumar 423 EMERGENCY ROOM VISITS IN PATIENTS WITH METASTATIC PROSTATE CANCER Khurshid R Ghani 1977 TRENDS IN UTILIZATION AND OUTCOMES FOR PERCUTANEOUS NEPHROLITHOTOMY IN THE UNITED STATES Khurshid R Ghani 1981 TRENDS IN SURGERY FOR UPPER URINARY TRACT STONES IN THE UNITED STATES: 1999-2009 Khurshid R Ghani 1289 ACUTE IMAGING FOR HEMATURIA IN THE UNITED STATES: COSTS AND PREDICTORS FROM THE NATIONWIDE EMERGENCY DEPARTMENT SAMPLE Jesse Sammon 1545 TRENDS IN UTILIZATION AND COMPARATIVE OUTCOMES FOR INFECTED UPPER URINARY TRACT STONES IN THE UNITED STATES: PCN VS. STENT Hanhan Li 1050 UTILIZATION AND PERI-OPERATIVE OUTCOMES OF ROBOT-ASSISTED AND OPEN VAGINAL VAULT SUSPENSION Jesse Sammon 2120 LIVE DONOR NEPHRECTOMY VS. KIDNEY TRANSPLANTS IN MINORITY POPULATIONS: A POPULATION BASED ANALYSIS OF TRENDS Khurshid R Ghani 721 IT'S THE WEEKEND! INCREASED MORTALITY IN METASTATIC PROSTATE CANCER PATIENTS VISITING THE EMERGENCY DEPARTMENT IN THE WEEKEND VS. WEEKDAY Jesse Sammon 1062 SOCIOECONOMIC TRENDS AND UTILIZATION IN THE EMERGENCY DEPARTMENT TREATMENT OF URINARY TRACT INFECTIONS Khurshid Guru 1764 COMPARATIVE ONCOLOGIC EFFECTIVENESS BETWEEN ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY -
AUA VUI 2012 Presentations
Presentor
Presentation
Vijayalakshmi Thamilselvan 2072 ROLE OF REACTIVE OXYGEN SPECIES AND CARDIOLIPIN PEROXIDATION IN OXALATE-INDUCED RENAL MITOCHONDRIAL DYSFUNCTION: EFFECT OF ANTIOXIDANTS Chris Wambi 1335 ONCOLOGIC OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN YOUNG MEN Quoc-Dien Trinh 1459 CLINICAL AND PATHOLOGIC FEATURES OF PROSTATE CANCER WITH PROSTATIC-SPECIFIC ANTIGEN (PSA) LESS THAN 2.5 NG/ML: A STUDY OF 209 CASES Khurshid R Ghani 999 CAN QUANTITATION AND SUB-CATEGORIZATION OF EXTRAPROSTATIC EXTENSION AT RADICAL PROSTATECTOMY PREDICT BIOCHEMICAL RECURRENCE? Michael Marean 358 CREATION OF A PREOPERATIVE NOMOGRAM THAT INCLUDES ENDORECTAL MRI ACCURATELY PREDICTS NON ORGAN-CONFINED PROSTATE CANCER Khurshid R Ghani V1033 ROBOT-ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION MODIFIED NERVE-SPARING LEFT SIDED TEMPLATE Quoc-Dien Trinh V405 ENUCLEATION TECHNIQUES FOR CHALLENGING ROBOT-ASSISTED PARTIAL NEPHRECTOMY CASES Jay Jhaveri V1027 ROBOT-ASSISTED SIMPLE PROSTATECTOMY Wooju Jeong V1890 ROBOT-ASSISTED PARTIAL CYSTECTOMY FOR BLADDER CANCER OF A BLADDER DIVERTICULUM Khurshid R Ghani V1891 INTRACORPOREAL ILEAL CONDUIT URINARY DIVERSION Jan Schmitges 1685 HIGHER PERIOPERATIVE MORBIDITY AND IN-HOSPITAL MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE UNDERGOING NEPHRECTOMY FOR NON-METASTATIC KIDNEY CANCER: A POPULATION-BASED ANALYSIS Jay Jhaveri V242 ROBOT-ASSISTED REPAIR OF RECURRENT VESICOVAGINAL FISTULA Quoc-Dien Trinh 687 DIFFERENCES IN PERIOPERATIVE OUTCOMES BETWEEN AFRICAN AMERICAN AND CAUCASIAN PATIENTS AFTER RADICAL PROSTATECTOMY Khurshid R Ghani 1602 A POPULATION-BASED ASSESSMENT OF OUTCOMES AFTER RADICAL CYSTECTOMY IN OCTOGENARIANS Khurshid R Ghani 693 IMPACT OF POSTERIOR RECONSTRUCTION OF DENONVILLIER'S MUSCULOFASCIAL PLATE ON ANASTOMOTIC LEAKAGE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY A PROPENSITY-SCORE MATCHED ANALYSIS Khurshid R Ghani 1466 PREOPERATIVE NOMOGRAM PREDICTING ERECTILE FUNCTION TWO YEARS AFTER RADICAL PROSTATECTOMY Quoc-Dien Trinh 1284 THE EFFECT OF GENDER ON NEPHRECTOMY PERIOPERATIVE OUTCOMES: A NATIONAL SURVEY Quoc-Dien Trinh 688 THE EFFECT OF HOSPITAL VS. SURGICAL VOLUME ON OUTCOMES AFTER RADICAL PROSTATECTOMY A HEAD-TO-HEAD COMPARISON USING DECISION-CURVE ANALYSES Quoc-Dien Trinh 1787 THE EFFECT OF NODAL CODING SCHEMES ON CANCER-SPECIFIC MORTALITY AFTER CYTOREDUCTIVE NEPHRECTOMY Quoc-Dien Trinh 1336 THE IMPACT OF HOSPITAL VOLUME, RESIDENCY AND FELLOWSHIP TRAINING ON COMPLICATIONS AFTER RADICAL PROSTATECTOMY Quoc-Dien Trinh 1338 PERIOPERATIVE OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY VS. OPEN RADICAL PROSTATECTOMY Quoc-Dien Trinh 426 DISPARITIES IN THE UTILIZATION OF PARTIAL NEPHRECTOMY IN THE UNITED STATES A CASE FOR CONCERN? Quoc-Dien Trinh 1103 ROBOT-ASSISTED VS. LAPAROSCOPIC PARTIAL NEPHRECTOMY UTILIZATION PATTERNS AND PERIOPERATIVE OUTCOMES IN THE UNITED STATES Kamran Ahmed 1161 COMPARISON OF OUTCOMES BETWEEN INTRA-CORPOREAL AND EXTRA-CORPOREAL URINARY DIVERSION AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY – THE IRCC RESULTS Matthew H Hayn 1407 IS ROBOT-ASSISTED RADICAL CYSTECTOMY EFFECTIVE FOR T3 BLADDER CANCER? RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM
EUA VUI Presentations
-
EAU VUI 2023 Presentations
Presentor
Presentation
Matt Davis #AM23-1737 Frequentist and Bayesian Analysis of Potential Adverse Events of the COVID-19 Immunization Matt Davis #AM23-3353 Baseline PSA levels in midlife & future development of lethal prostate cancer: A diverse North American cohort analysis Matt Davis #AM23-4962 Racial disparities in future development of lethal prostate cancer based on PSA levels in midlife Ivan Rakic Evaluating the role of lymphvascular invasion as an indicator for adverse outcomes for patients with upper tract urothelial carcinoma and its histological subtypes Ivan Rakic The impact of histological subtypes on stage at presentation and overall survival of patients with upper tract urothelial carcinoma: A nationwide cohort analysis Sohrab Arora 23-8647 Inpatient outcomes of radical nephroureterectomy (NU) for upper tract urothelial cancer (UTUC), with trends in utilization and impact of robotic surgery – National Inpatient Sample (NIS) analysis. Sohrab Arora Outcomes of Precision Prostatectomy procedure for localized prostate cancer, and step-by-step technique of single port transvesical Precision Prostatectomy Nick Corsi Testing the external validity of the pout III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort Nick Corsi Radical therapy for low-risk upper tract urothelial carcinoma (ROBUUST collaborative group) Nick Corsi Perioperative and Functional Outcomes of Greenlight 180-W Photovaporization in Large (>80 cc) Prostates: an Analysis from 7 Centers in the International Global Greenlight Group Matt Davis #AM23-3251 Industry Payments to Urologists Since the Sunshine Act Matt Davis #AM23-3261 Industry Payments to Urologists Since the COVID-19 Pandemic Matt Davis #AM23-3218 Evaluating The Impact of COVID-19 Pandemic on Prostate-Specific Antigen Testing in a North American Population: a health system-wide analysis Matt Davis #AM23-3219 Impact of Age and Race on Prostate-Specific Antigen Testing in Response to the COVID-19 Pandemic Matt Davis #AM23-3384 Is there a Role for Radical Cystectomy in treating patients with Metastatic Plasmacytoid Bladder Cancer Patients? A Nationwide cohort analysis. Matt Davis #AM23-3149 Impact of PSA testing pattern on cancer mortality among Black and White men diagnosed with prostate cancer: A large, urban health system cohort analysis Matt Davis #AM23-3276 Gender Gap in Industry Payments to Urologists Taylor Malchow Application and survival outcomes of landmark prostate specific antigen screening trial protocols in an urban healthcare system Ivan Rakic Is there a racial disparity in the outcomes of patients with non-metastatic upper urothelial carcinoma who are treated surgically? A north american nationwide analysis Sohrab Arora 23-8612
Do saturation prostate biopsies provide additional clinically significant information in patients with MRI identified lesions sampled at the same time?Sohrab Arora Impact of a novel anterior suspension stitch on return of urinary continence after Robot-assisted Radical Prostatectomy with description of surgical technique Sohrab Arora 23-8594 Inpatient outcomes of simultaneous radical cystectomy and nephroureterectomy in the United States: Retrospective analysis of the National Inpatient Sample Sami Wilder -
EAU VUI 2022 Presentations
Presentor
Presentation
Ivan Rakic Evaluation of the utility of lymph-vascular invasion as an independent prognostic predictor of overall survival for patients with renal cell carcinoma that undergo nephrectomy Mohit Practice-level variation in rates positive surgical margins at partial nephrectomy: a MUSIC-KIDNEY analysis Mohit Reducing post-operative emergency department visits and readmissions after nephrectomy: an initial evaluation of the MUSIC-KIDNEY registry Mohit Evaluation of an uncomplicated recovery after nephrectomy: MUSIC-KIDNEY NOTES (Notable Outcomes and Trackable Events after Surgery) Nick Corsi Who is shaping the future of urology? A descriptive analysis of current urology residency program directors Mohit Assessing renal mass management of patients with increased comorbidities: Results from a statewide registry Abdollah The impact of Adjuvant chemotherapy on overall survival in patients with node-positive upper tract urothelial carcinoma (UTUC): improving precision in medicine with a risk-stratified approach. AJ Piontkowski Benefit of lymph node dissection in cn+ patients in the treatment of upper tract urothelial carcinoma: Analysis of ncdb registry Nick Corsi External validation of the Bladder Cancer Research Consortium (BCRC) nomogram for predicting survival after radical cystectomy -
EAU VUI 2021 Presentations
Presentor
Presentation
Modonutti P0861: A multi-trial based external validation of the Halabi nomogram in predicting the overall survival of metastatic castration-resistant prostate cancer patients Marcus Jamil P0640
Renal mass size and presence of synchronous lung metastasis at time of diagnosis: Implications for chest imagingSohrab Arora Impact of preexisting opioid-dependence on morbidity, length of stay, and inpatient cost of urologic oncologic surgery Nicholas Corsi Recurrence-free survival following resection of low-grade, Non-Muscle-Invasive Urothelial Cancer (NMIBC): A Southwest Oncology Group (SWOG) S0337 post-hoc analysis Nikola Rakic P1217: Evaluation of the utility of lymphovascular invasion as a complementary or independent prognostic predictor of overall survival after radical prostatectomy Volpe A 429: Robot-assisted partial nephrectomy for cT1b-T2 renal tumors: Perioperative outcomes from a large multicentre international dataset (Vattikuti Global Quality Initiative on Robotic Urologic Surgery) Nicholas Corsi Estimating recurrence free survivability of Non-Muscle Invasive Bladder Cancer (NMIBC) after intravesical therapy: A clinical-based recursive partition analysis Modonutti A multi-trial based external validation of the Halabi nomogram in predicting the overall survival of metastatic castration-resistant prostate cancer patients Chandler Bronkema National Cancer Database analysis assessing the impact of treatment modalities on survival outcomes in localized neuroendocrine prostate adenocarcinoma Akshay Sood Anti-androgen therapy overcomes the time-delay in initiation of salvage radiation therapy and rescues the oncological outcomes in men with recurrent prostate cancer after radical prostatectomy: A post-hoc analysis of the RTOG 9601 trial data -
EAU VUI 2020 Presentations
Presentor
Presentation
Marcus Jamil PT182: Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort Firas Abdollah 684: External validation of genomic classifier based risk-stratification tool to identify candidates for adjuvant radiation therapy in patients with prostate cancer Marcus Jamil PT182: Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort Chandler Bronkema 1118: Impact of treatment modality on overall survival (OS) in localized ductal prostate adenocarcinoma (PCa): A national cancer database (NCDB) analysis M Bhandari PT186: Predicting intraoperative complications and 30-days morbidity using machine learning techniques for patients undergoing robotic partial nephrectomy (RPN) Cone, EB 576: Lower odds of cardiac events for gonadotropic releasing hormone antagonists versus agonists Cone, EB 565: Abiraterone is associated with higher odds of cardiac complications compared to enzalutamide Veccia, A 164: Robotic radical nephroureterectomy for upper tract urothelial carcinoma: data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group Cone, EB 718: Checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy Veccia, A 161: Safety profile of robotic vs laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group M Bhandari P0332: Complexities in annotating surgical videos for building supervised deep learning models for critical steps of laparoscopic live donor nephrectomy -
EAU VUI 2019 Presentations
Presentor
Presentation
Sohrab Arora 162: Rare histological variants of prostate adenocarcinoma (PCa): A National Cancer Database (NCDB) analysis Akshay Sood PT389: Extended lymph node dissection is associated with improved overall survival in patients with very high-risk prostate cancer: A national cancer database analysis Firas Abdollah 473: Menon-precision prostatectomy (MPP): An idea, development, exploration, assessment, long-term follow-up (IDEAL) stage 1 study Akshay Sood 650: Rates and patterns of metastases in patients with node-negative prostate cancer at radical prostatectomy that experience PSA failure: Post-hoc analysis of RTOG 9601 trial data Firas Abdollah 647: Evaluating the impact of lead-time bias on the observed efficacy of early salvage radiation therapy in prostate cancer: A post-hoc analysis of the RTOG 9601 trial Nikola Rakic 723: Persistent under-utilization of adjuvant radiotherapy in patients with adverse pathological features at radical prostatectomy: A national cancer database (NCDB) analysis Sohrab Arora 1036: Inpatient morbidity and cost of cytoreductive radical prostatectomy in the United States Alexander P Cole 639: A smartphone-based mobile health app to address the adverse effects of androgen deprivation therapy in men with prostate cancer Akshay Sood PT389: Extended lymph node dissection is associated with improved overall survival in patients with very high-risk prostate cancer: A national cancer database analysis Sohrab Arora 874: Testing the external validity of CARMENA trial comparing sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma Sohrab Arora 1194: Feasibility of omitting outer (cortical) renorrhaphy during robotic partial nephrectomy - a multi-institutional analysis Fotouhi PT374: The changing face of surgically treated low-risk prostate cancer (PCa): A national cancer database (NCDB) analysis Amit Patel 910: Patterns of renal mass biopsy across the MUSIC-KIDNEY statewide QI collaborative Sohrab Arora 162: Rare histological variants of prostate adenocarcinoma (PCa): A National Cancer Database (NCDB) analysis Firas Abdollah PT282: Defining the indications for pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients within a statewide quality improvement collaborative Tan WS 222: Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer Alexander P Cole PT322: The contribution of demographic, access and treatment-related factors on racial disparities in bladder cancer -
EAU VUI 2018 Presentations
Presentor
Presentation
Firas Abdollah 162: Assessing the external validity of the updated prostate cancer (PCa) intervention versus observation trial (PIVOT) Firas Abdollah 162: Assessing the external validity of the updated prostate cancer (PCa) intervention versus observation trial (PIVOT) Von Landenberg 90: Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy Fletcher, S 1070: Contemporary national trends in localized prostate cancer risk profile at diagnosis Zaffuto, E 675: Which patients with low-risk prostate cancer are still receiving radical prostatectomy? Impact of patient selection on inverse stage migration at two European, tertiary referral centers Bandini PT123: Increasing trend of non-interventional treatment management in patients candidate to active surveillance with localized prostate cancer Marchioni, M 1041: Comparison of partial vs. radical nephrectomy effect on other cause mortality, cancer specific mortality and 30-day mortality in patients older than 75 years Bandini 822: Contemporary trends and survival outcomes after aborted radical prostatectomy in lymph node metastatic prostate cancer patients -
EAU VUI 2017 Presentations
Presentor
Presentation
Mani Menon 936: Urinary continence, sexual function and biochemical recurrence 12 months following robot-assisted radical prostatectomy: A randomized controlled study comparing the Bocciardi and Menon techniques Christian Meyer 533: Antimuscarinic use in the elderly: A poisoned apple? Thomas Seisen 274: Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder Björn Löppenberg 794: Variation in the use of active surveillance for low-risk prostate cancer Christian Meyer 181: Comparative effectiveness of transurethral resection techniques for benign prostatic hyperplasia – analysis of an all payer in patient discharge database Mani Menon 936: Urinary continence, sexual function and biochemical recurrence 12 months following robot-assisted radical prostatectomy: A randomized controlled study comparing the Bocciardi and Menon techniques Thomas Seisen 172: Adjuvant chemotherapy vs. observation following radical cystectomy for pT3-4 and/or pN+ urothelial carcinoma of the bladder previously treated with neoadjuvant chemotherapy Philipp Gild 238: The use of prostate-specific antigen screening in purchased versus direct care settings: Data from the TRICARE military database Thomas Seisen 173: Comparative effectiveness of selective adjuvant versus systematic neoadjuvant chemotherapy-based strategy for muscle-invasive urothelial carcinoma of the bladder Deepansh Dalela 951: Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model Philipp Gild 648: Contemporary incidence and epidemiologic trends of brain metastases at renal cell carcinoma diagnosis Björn Löppenberg 800: Variation in prostate cancer care at commission on cancer designated facilities -
EAU VUI 2016 Presentations
Presentor
Presentation
Akshay Sood 485: Complications after adrenalectomy – does the speciality matter? Gandaglia 409: Preoperative predictors of renal failure after robot-assisted partial nephrectomy: Analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database Akshay Sood 715: Robotic kidney transplantation with regional hypothermia: Results from a prospective two-arm non-randomized controlled trial (Ideal phase 2b) Christian Meyer 669: Surgeon and hospital variation in the costs of robot-assisted radical prostatectomy in the United States Christian Meyer 755: Trends of metastasectomy for metastatic renal cell carcinoma and their impact on overall survival Ross, A 435: Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk Khurshid R Ghani 364: Assessment of surgical competency for robot-assisted radical prostatectomy: Development and validation of Prostatectomy Assessment and Competency Evaluation (PACE) Hanna, N 94: Informed decision-making for prostate-specific antigen screening Christian Meyer 93: A nationwide survey of prostate specific antigen based screening and counseling for prostate cancer Deepansh Dalela 412: Outcomes of robot-assisted partial nephrectomy in patients with complex renal tumours and pre-existing chronic kidney disease in a multi-institutional, multinational database Christian Meyer 71: Morbidity, mortality and costs of treatment for locally advanced prostate cancer: A population-based analysis comparing radical prostatectomy and external beam radiation Christian Meyer 90: Differences in prostate specific antigen testing among urologists and primary care providers in the United States following the 2011 USPSTF recommendations Björn Löppenberg 7: Sling procedures for female stress incontinence: Does surgical specialty matter? Christian Meyer 443: Minimally invasive vs open radical prostatectomy: An analysis of 30-day postoperative complications, unplanned readmissions, and mortality Malte W Vetterlein 632: Radical cystectomy for bladder cancer vs non-malignant indications: Preoperative predictors of perioperative outcomes in a sample of 3269 patients -
EAU VUI 2015 Presentations
Presentor
Presentation
Deepansh Dalela 923: Impact of annual surgical volume on outcomes of robot-assisted partial nephrectomy in a multi-institutional, multinational cohort Fossati, N 801: The impact of insurance status on tumor characteristics and treatment selection in contemporary prostate cancer patients Fossati, N 823: Contemporary management of prostate cancer patients suitable for active surveillance: A population-based study Larcher, A 924: Predicting perioperative outcomes of robot assisted partial nephrectomy: The role of hospital case volume in the early phase of adoption Hanske, J 1060: Female urethral diverticulectomy perioperative outcomes of a multi-institutional prospective database Marianne Schmidt 641: Racial disparities in the surgical care of localized prostate cancer Hanske, J 337: Perioperative outcomes of open versus minimally invasive nephroureterectomy: An analysis of 896 patients from the ACS NSQIP database Hanske, J 599: The impact of metastatic disease at retroperitoneal lymph node dissection for testis cancer on postoperative outcomes Hanske, J 1059: Vesico-vaginal fistula repair: Perioperative outcomes of abdominal vs vaginal approaches Akshay Sood 611: Incidence, national trends and disparities in the surgical management for testicular torsion in boys Christian Meyer 620: Open versus robot-assisted radical prostatectomy: A contemporary analysis of an all-payer discharge database Roghmann, F 435: Perioperative outcomes after radical cystectomy at NCI-designated centers: Are they any better? Christian Meyer 442: The impact of preoperative hypoalbuminemia on perioperative outcomes after radical cystectomy in 1,262 patients Christian Meyer 436: Predictors of wound dehiscence in a prospective dataset of 2,586 cystectomies James O Peabody 192: Wisdom of the crowds: Use of crowdsourcing to assess surgical skill of robot-assisted radical prostatectomy in a statewide surgical collaborative Firas Abdollah 1011: Adjuvant radiotherapy in prostate cancer patients treated with surgery: The impact of age and tumour characteristics Firas Abdollah 638: Androgen deprivation therapy and increased non-cancer mortality in prostate cancer patients: Analysis of the number needed to harm Khurshid R Ghani 483: Video-based independent peer review of robot-assisted radical prostatectomy in a statewide quality improvement collaborative Firas Abdollah 1016: Long-term clinical recurrence (CR) rate in prostate cancer (PCa) patients with adverse pathological characteristics at robotic-assisted laparoscopic radical prostatectomy (RALP) Akshay Sood 842: Robotic kidney transplantation with regional hypothermia: Results from a prospective two-arm non-randomized controlled trial (Ideal Phase 2b) Akshay Sood 978: Robotic anatrophic nephrolithotomy using near infra-red fluorescence image-guidance: Idea, Development, Exploration, Assessment and Long-term monitoring (IDEAL) phase 0 study Deepansh Dalela 921: Perioperative and functional outcomes of robot-assisted partial nephrectomy for renal tumors >4 cm in a multi-institutional, multinational cohort Firas Abdollah 938: When should a positive surgical margin (SM) ring a bell? An analysis of a multi-institutional Robotic-Assisted Laparoscopic radical Prostatectomy (RALP) database Firas Abdollah 191: Cancer-control outcomes in patients with clinically high-risk prostate cancer (PCa) treated with robotic-assisted laparoscopic radical prostatectomy (RALP): A multi-institutional database analysis -
EAU VUI 2014 Presentations
Presentor
Presentation
Roghmann 645: Radical prostatectomy vs radiotherapy among older patients with clinically advanced prostate cancer Shoshtari 428: Comparison of peri-operative outcomes of robotic partial nephrectomy and laparoscopic partial nephrectomy in surgical treatment of small renal masses Hay, D 877: Systematic review of effectiveness of mentorship programmes in urology -
EAU VUI 2013 Presentations
Presentor
Presentation
Khurshid R Ghani 260: Outcomes for open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: Results from the Nationwide Inpatient Sample Jesse Sammon 915: Robot-assisted vs open radical prostatectomy: A comparison of outcomes across procedure type and volume quartile Hanhan Li 119: Utilization and peri-operative outcomes of robot-assisted and open vaginal vault suspension Wooju Jeong 709: Bimanual examination of retrieved specimen during robot-assisted radical prostatectomy: A novel technique for reducing the positive surgical margin Ramesh Kumar Complications during robot-assisted kidney surgery Wooju Jeong Bimanual examination of retrieved specimen and selective hypothermia during robot-assisted radical prostatectomy Jesse Sammon 158: Socioeconomic trends and utilization in the emergency department treatment of urinary tract infections Kaczmarek 876: Perioperative and functional outcomes of robotic assisted partial nephrectomy without hilar clamping: A multi-institutional propensity score analysis Khurshid R Ghani 260: Outcomes for open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: Results from the Nationwide Inpatient Sample Khurshid R Ghani 659: Trends in utilization and outcomes for percutaneous nephrolithotomy in the United States Jesse Sammon 915: Robot-assisted vs open radical prostatectomy: A comparison of outcomes across procedure type and volume quartile Jesse Sammon 1070: Trends in utilization and comparative outcomes for infected upper urinary tract stones in the United States: PCN vs stent Jesse Sammon 497: Live donor nephrectomy vs kidney transplants in minority populations: A population based analysis of trends Jesse Sammon 158: Socioeconomic trends and utilization in the emergency department treatment of urinary tract infections Jesse Sammon 625: Predictors of admission in patients presenting to the emergency department with urinary tract infection Khurshid R Ghani 657: It’s getting hot in here! Monthly variation in emergency department visits for upper urinary tract calculi in the United States Penna, FJ 526: Prevalence and temporal trends in admissions for urolithiasis in children Shyam Sukumar 534: Correction of ureteropelvic junction obstruction in children: National trends and comparative effectiveness in operative outcomes Khurshid R Ghani 369: Acute imaging for hematuria in the United States: Costs and predictors from the Nationwide Emergency Department Sample Craig G Rogers 885: Intracorporeal cooling and extraction (I.C.E.) technique of robotic partial nephrectomy: Emulating the open approach Craig G Rogers Robotic partial nephrectomy with cold ischemia and early tumor extraction: Recapitulating the open approach -
EAU VUI 2012 Presentations
Presentor
Presentation
Quoc-Dien Trinh Complications during robot-assisted kidney surgery Quoc-Dien Trinh Enucleation techniques for challenging robot-assisted partial nephrectomy cases Khurshid R Ghani Robot-assisted retroperitoneal lymph node dissection: Modified nerve-sparing left sided template Quoc-Dien Trinh 679: Perioperative outcomes of robot-assisted radical prostatectomy vs. open radical prostatectomy Khurshid R Ghani 1061: Accurate prediction of erectile function following robot-assisted radical prostatectomy Quoc-Dien Trinh 134: Disparities in the utilization of partial nephrectomy in The United States: A case for concern? Quoc-Dien Trinh 677: The effect of hospital vs. surgical volume on outcomes after radical prostatectomy: A head-to-head comparison using decision-curve analyses
NARUS and World Congress Presentations
-
UI presentations at NARUS 2017
Presentor
Presentation
Sohrab Arora, Rajesh Ahlawat. Robot assisted partial nephrectomy for complex renal hilar tumors: Technical caveats. Presented at the North American Robotic Urology Symposium, Las Vegas, February 2017. Sohrab Arora, Rajesh Ahlawat Robotic Excision Of A Functioning Hilar Paraganglioma With Reconstruction of Renal Vessels. Presented at the North American Robotic Urology Symposium, Las Vegas, February 2017. Sohrab Arora, Rajesh Ahlawat. A novel technique of intrafascial robotic radical prostatectomy with combined anterior-posterior approach to preserve continence mechanism - A Feasibility study. Presented at the North American Robotic Urology Symposium, Las Vegas, February 2017. Won the second prize for the best video Deepansh Dalela, Wooju Jeong, Madhu-Ashni Prasad, Akshay Sood, Firas Abdollah, Patrick Karabon, Mireya Diaz, Jesse Sammon, Marcus Jamil, Brad Baize, Andrea Simone, Mani Menon A pragmatic randomized controlled trial examining the impact of the Retzius- sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy - Awarded Best Poster Mani Menon, Deepansh Dalela, Madhu-Ashni Prasad, Marcus Jamil, Akshay Sood, Firas Abdollah, Patrick Karabon, Mireya Diaz, Jesse Sammon, Christopher Tallman, Brad Baize, Andrea Simone, Wooju Jeong Functional recovery, oncologic outcomes and postoperative complications 12 months following robot-assisted radical prostatectomy: results of an evidence- based analysis comparing the ‘Bocciardi’ and ‘Menon’ techniques Mani Menon, Deepansh Dalela, Madhu-Ashni Prasad, Marcus Jamil, Akshay Sood, Firas Abdollah, Patrick Karabon, Mireya Diaz, Jesse Sammon, Christopher Tallman, Brad Baize, Andrea Simone, Wooju Jeong Learning Curve and patient safety monitoring for an experienced surgeon performing a new procedure: results from an IDEAL Phase 3 study comparing two techniques if robot-assisted radical prostatectomy. -
World Congress of Endourology 2017
Presentor
Presentation
Sohrab Arora, Rajesh K. Ahlawat, Ronney Abaza, James Adshead, Ben Challacombe, Prokar Dasgupta, Giorgio Gandaglia, DA Moon, Giacomo Novara, F Porpiglia, James Porter, Alex Mottrie, Mahendra Bhandari, Craig Rogers. Trifecta outcomes of robot-assisted partial nephrectomy in solitary kidney - A GQI-RUS database analysis. Sohrab Arora, Rajesh K. Ahlawat, Ronney Abaza, James Adshead, Ben Challacombe, Prokar Dasgupta, Giorgio Gandaglia, DA Moon, Giacomo Novara, F Porpiglia, Alex Mottrie, Mahendra Bhandari, Craig Rogers and James Porter. Retroperitoneal vs. transperitoneal robot assisted partial nephrectomy – an propensity score weighted comparison in the GQI-RUS database analysis. Sohrab Arora, Rajesh K. Ahlawat, Ronney Abaza, James Adshead, Ben Challacombe, Prokar Dasgupta, Giorgio Gandaglia, DA Moon, Giacomo Novara, F Porpiglia, James Porter, Alex Mottrie, Mahendra Bhandari, Craig Rogers. A Vattikuti Collective Quality Initiative database analysis. Harmanjit Gill, Craig Rogers Outcomes of robot-assisted partial nephrectomies in high volume centers continue to improve for several years after the initial learning curve – Poster Presentation Harmanjit Gill, Craig Rogers Concurrent robotic kidney and general surgery procedures – Video Abstract
Total AUA Count
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Total |
| Abstracts | 25 | 19 | 14 | 39 | 26 | 32 | 24 | 17 | 14 | 31 | 15 | 20 | 276 |
Total EUA Count
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Total |
| Abstracts | 7 | 21 | 3 | 24 | 15 | 12 | 9 | 17 | 11 | 10 | 9 | 10 | 148 |
Information for Applicants
Interested in applying to one of our programs, call (800) 436-7936 .